Ivan

He who sees the future wins. IYKYK

During #WorldOptometryWeek, we recognize the power of collaboration in expanding access to eye care. At Ocugen, we are driving gene therapy innovation for major blindness diseases to help address critical unmet needs in vision care. @WorldCouncilOpt #EyeHealth #GeneTherapy

$OCGN Clinical Trial Results: On March 24, 2026, Ocugen, Inc. reported topline data from the Phase 2 ArMaDa clinical trial evaluating its OCU410 gene therapy for geographic atrophy caused by dry age-related macular degeneration, and a conference call is scheduled for the same day to discuss the data. stockinsights.ai/us/OCGN/8-K/pr…

New Research Report: Ocugen (OCGN) – Raising Price Target After Positive OCU410 Data Reported $OCGN #Investing #EquityResearch #Biotechnology #GeneTherapy channelchek.com/news-channel/o…

@Diego48979433 😅

@IvandeaGreat That's me lol

$OCGN People who have been in OCGN for 5 years

@treemaga Analysts estimates are 12-18 months PT. Ocugen has 3 BLA’s scheduled in three years. That should give us plenty of PR’s. Takes time thats all.

@IvandeaGreat What’s the deal with all of these Oppenheimer etc, giving bullshit ratings and then nada

@GuyCreal 💯 😅

@IvandeaGreat That’s about right 😆

FDA’s new guidance on Bayesian statistics is creating a lot of buzz! “The importance of the guidance cannot be overstated. It underscores FDA’s commitment to modernizing clinical research and promoting the use of bayesian methods in clinical trials.” jamanetwork.com/journals/jama/…

$ocgn channelchek.com/news-channel/o…

Optimus

@makinitrainkid @NattaCop Lol Loads of paper hands. This was but a tickle…

@NattaCop @IvandeaGreat Didn't even flinch 😂

$ocgn just showed they have the new standard of care for GA, phase 3 starts this year, market dumps early retail panics, everyone worrying about results that point to the next standard of care… Next OCU410ST Pivotal 2/3 announces enrollment completion, another blockbuster clock starts, this one comes with a PRV on approval which will be worth around $200-$250 million. OCU400 rolling BLA starts, will target 99% of the RP market and Ocugen will transform from a pre revenue bio to a leader in gene therapy’s. You can choose to focus on the day to day noise, worry about the volatility and question what you own. Or you can focus on the facts, capitalize and enjoy knowing you own the next pharmaceutical giant before the rest of the world catches on. No 🧠’er 🍻 🐂

Today, CEO @drsmusunuri shares encouraging 12-month Phase 2 results for #OCU410 in GA, showing impact on lesion growth and visual function. A one-time gene therapy approach with potential to shift the landscape and address unmet needs.   Read more: bit.ly/4lLGXYV

@NoLimitGains UK and their elites did. Ukraine is the puppet. IYKYK

🚨 UKRAINE JUST HIT RUSSIA’S LARGEST OIL PORT: – Primorsk. Russia’s biggest oil export terminal on the Baltic – Handles 1.5 million barrels per day, 60 million tons per year – It’s on fire, fuel reservoirs burning, workers evacuated, operations suspended – The nearby Ust-Luga port also suspended operations – Russia’s TWO largest petroleum export outlets offline at the same time – Ukraine confirmed the strike, 249 drones launched – Both the tank farm and oil loading infrastructure were hit – Primorsk is where Russia’s shadow fleet loads up to dodge sanctions – It’s how Russian oil money keeps flowing despite every Western sanction Now think about the timing… – The Strait of Hormuz is closed. 20% of global oil choked off because of the Iran war – Now Russia’s biggest Baltic export hub is also offline – The Novorossiysk Black Sea port was hit by drones earlier this month too – Global oil supply is being squeezed from two directions at the same time. The Middle East AND Russia. Simultaneously I’ll share more updates shortly, turn on notifications so you don’t miss anything important.

$OCGN #OCUGEN 👇 👇 👇 👇 Why would you have top doctors in a field on a conference call unless it's really good data to present!!! 🤫🤫🤫

Ocugen will host a live webcast Mar 24 at 8 a.m. EDT on Phase 2 ArMaDa data for #OCU410 in GA, led by KOLs Lejla Vajzovic, MD, and Jay Chhablani, MD. Don’t miss key insights into advancements in modifier gene therapy for retinal disease. Details: bit.ly/4uJ8GgG

@elonmusk Brilliant!

Terafab was the final missing piece of the puzzle

@xai This gave me the chills. Im pumped for the future! Thank you Elon!

In order to understand the universe, you must explore the universe → x.ai/careers

@50cent @50CentAction247 Oh fuck! 💀🤣